2020
Activation of the Nitric Oxide Pathway and Acute Myocardial Infarction Complicated by Acute Kidney Injury
PAŘENICA, Jiří, Petr KALA, Alexandre MEBAZAA, Simona LITTNEROVÁ, Klára BENEŠOVÁ et. al.Základní údaje
Originální název
Activation of the Nitric Oxide Pathway and Acute Myocardial Infarction Complicated by Acute Kidney Injury
Autoři
PAŘENICA, Jiří (203 Česká republika, domácí), Petr KALA (203 Česká republika, domácí), Alexandre MEBAZAA (250 Francie), Simona LITTNEROVÁ (203 Česká republika, domácí), Klára BENEŠOVÁ (203 Česká republika, domácí), Josef TOMANDL (203 Česká republika, domácí), Monika PÁVKOVÁ GOLDBERGOVÁ (203 Česká republika, domácí), Jiří JARKOVSKÝ (203 Česká republika, domácí), Jindřich ŠPINAR (203 Česká republika, domácí), Marie TOMANDLOVÁ (203 Česká republika, domácí), Milan DASTYCH (203 Česká republika, domácí), Can INCE (528 Nizozemské království), Kateřina HELÁNOVÁ (203 Česká republika, domácí), Martin TESÁK (203 Česká republika, domácí), Martin HELÁN (203 Česká republika, domácí), Petr LOKAJ (203 Česká republika, domácí) a Matthieu LEGRAND (250 Francie, garant)
Vydání
CARDIORENAL MEDICINE, BASEL, KARGER, 2020, 1664-3828
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30201 Cardiac and Cardiovascular systems
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.041
Kód RIV
RIV/00216224:14110/20:00115794
Organizační jednotka
Lékařská fakulta
UT WoS
000526816300002
Klíčová slova anglicky
Acute kidney injury; Nitric oxide; Myocardial infarction; Oxidative stress; Cardio renal
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 31. 8. 2020 12:01, Mgr. Tereza Miškechová
Anotace
V originále
Background/Aims: The pathophysiology of acute kidney injury (AKI) in ST-elevation myocardial infarction (STEMI) patients remains poorly explored. The involvement of the nitric oxide (NO) pathway has been demonstrated in experimental ischemic AKI. The aim of this study was to assess the predictive value of circulating biomarkers of the NO pathway for AKI in STEMI patients. Methods: Four hundred and twenty-seven STEMI patients treated with primary percutaneous coronary intervention were included. The primary end point was AKI. Biomarkers of the NO pathway (plasma superoxide dismutase [SOD], uric acid, nitrite/nitrate [NOx], neopterin) as well as cardiac biomarkers (B-type natriuretic peptide [BNP] and troponin) were sampled 12 h after admission. The predictive value of circulating biomarkers was evaluated in addition to the multivariate clinical model. Results: AKI developed in 8.9% of patients. The 3-month mortality was significantly higher in patients with AKI (34.2 vs. 4.1%; p < 0.001). SOD, uric acid, NOx, neopterin, BNP and troponin were significantly associated with the development of AKI (area under curve [AUC]-receiver operating curve [ROC] ranging between 0.70 and 0.81). In multivariate analysis cardiogenic shock, neopterin, NOx and troponin were independent predictors of AKI. AUC-ROC of the association of multibiomarkers and clinical model was 0.90 and outperformed the predictive value of the clinical model alone. OR of NOx >= 45 mu mol/L was 8.0 (95% CI 3.1-20.6) for AKI. Conclusion: Biomarkers of the NO pathway are associated with the development of AKI in STEMI patients. These results provide insights into the pathophysiology of AKI and may serve at developing preventing strategies for AKI targeting this pathway.
Návaznosti
MUNI/A/1250/2017, interní kód MU |
|